Hemlibra® (emicizumab-kxwh) for the Treatment of Haemophilia A with Inhibitors

Hemlibra® (emicizumab-kxwh) is an antibody indicated to reduce the frequency of bleeding episodes in adults and children with haemophilia A with factor VIII inhibitors.